Lithuanian company Atrandi Biosciences develops modern, easily adaptable solutions and tools for high-throughput screening (HTS) research. Their droplet microfluidics technology enables specialists to compartmentalize molecular biology reactions into millions of picoliter droplets and study biological samples at the resolution of single cells and individual molecules.
